Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants
Sebastian Weigang, Jonas Fuchs, Gert Zimmer, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

The evolution of SARS-CoV-2
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 724
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape
Sandile Cele, Farina Karim, Gila Lustig, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 2, pp. 154-162.e5
Open Access | Times Cited: 193
Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events
Junxian Ou, Wendong Lan, Xiaowei Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 187
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Verity Hill, Louis du Plessis, Thomas P. Peacock, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 127
Recurrent SARS-CoV-2 mutations in immunodeficient patients
Samuel Wilkinson, Alex Richter, Anna Casey, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 104
Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host
Sissy Therese Sonnleitner, Martina Prelog, Stefanie Sonnleitner, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 94
COVID-19: Challenges of Viral Variants
Jana L. Jacobs, Ghady Haidar, John W. Mellors
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 31-53
Open Access | Times Cited: 85
Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection
Chrispin Chaguza, Anne M. Hahn, Mary E. Petrone, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100943-100943
Open Access | Times Cited: 74
Persistent SARS-CoV-2 infection: significance and implications
Heather Machkovech, Anne M. Hahn, Jacqueline Garonzik‐Wang, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 7, pp. e453-e462
Open Access | Times Cited: 57
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency
Yijia Li, Manish C. Choudhary, James Regan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 731
Open Access | Times Cited: 48
The Emergence and Evolution of SARS-CoV-2
Edward C. Holmes
Annual Review of Virology (2024) Vol. 11, Iss. 1, pp. 21-42
Closed Access | Times Cited: 25
Immunocompromised Patients with Protracted COVID-19: a Review of “Long Persisters”
M. Veronica Dioverti, Sonsoles Salto‐Alejandre, Ghady Haidar
Current Transplantation Reports (2022) Vol. 9, Iss. 4, pp. 209-218
Open Access | Times Cited: 56
Want to prevent pandemics? Stop spillovers
Neil M. Vora, Lee Hannah, Susan Lieberman, et al.
Nature (2022) Vol. 605, Iss. 7910, pp. 419-422
Open Access | Times Cited: 54
The future of evolutionary medicine: sparking innovation in biomedicine and public health
Barbara Natterson-Horowitz, Athena Aktipis, Molly Fox, et al.
Frontiers in Science (2023) Vol. 1
Open Access | Times Cited: 31
Generation and Functional Analysis of Defective Viral Genomes during SARS-CoV-2 Infection
Terry Zhou, Nora J. Gilliam, Sizhen Li, et al.
mBio (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 26
SARS-CoV-2 evolution during prolonged infection in immunocompromised patients
Andrew D. Marques, Jevon Graham-Wooten, Ayannah S. Fitzgerald, et al.
mBio (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 10
SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs
Sho Iketani, David D. Ho
Cell chemical biology (2024) Vol. 31, Iss. 4, pp. 632-657
Open Access | Times Cited: 7
Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review
Daniele Focosi, Fabrizio Maggi, Massimo Franchini, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 29-29
Open Access | Times Cited: 54
SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient
Erika Quaranta, Alice Fusaro, Edoardo Giussani, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 444-448
Open Access | Times Cited: 35
Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2
Jessica Wagoner, Shawn Herring, Tien-Ying Hsiang, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 34
Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection
Chrispin Chaguza, Anne M. Hahn, Mary E. Petrone, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 32
Epidemic spreading under mutually independent intra- and inter-host pathogen evolution
Xiyun Zhang, Zhongyuan Ruan, Muhua Zheng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30
Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts
Karrie Kwan Ki Ko, Hatairat Yingtaweesittikul, Thuan Tong Tan, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 28
SARS-CoV-2 Transmission from Human to Pet and Suspected Transmission from Pet to Human, Thailand
Chutchai Piewbang, Panida Poonsin, Pattiya Lohavicharn, et al.
Journal of Clinical Microbiology (2022) Vol. 60, Iss. 11
Open Access | Times Cited: 28
Developing an appropriate evolutionary baseline model for the study of SARS-CoV-2 patient samples
John W. Terbot, Parul Johri, Schuyler Liphardt, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1011265-e1011265
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top